ASTCT Response to FDA Approval of Gene Therapies for Treatment of Sickle Cell Disease (SCD)
The American Society for Transplantation and Cellular Therapy® (ASTCT®) recognizes the US Food and Drug Administration’s (FDA) recently granted approval for two gene therapies aimed...
The Assistance Fund Opens New Program for Sickle Cell Disease
Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Sickle Cell Disease The Assistance Fund, an independent charitable patient assistance organization...